2026-10-11T11:55:53Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34055440 2026-10-02T07:22:39Z category_37339 category_37354 category_37360 category_37366 category_37375 portal_1012 item_type_3 month_year_10_2026

Table S1 from CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor–Resistant HR+/HER2− Breast Cancer Dejan Juric (15126249) Kazi N. Islam (25300822) Ioanna-Maria Gkotinakou (25300825) Alice Zheng (25300828) Hanjun Lee (25300831) Sneha Saxena (25300834) Johannes Kreuzer (22180737) Robert Morris (22180734) Connor G. McGrath (25300837) Ramin Sakhtemani (25300840) Nicholas J. Chevalier (23661211) Allison M. Kehlmann (17931613) Anastasia Maria Stavridi (25300843) Shahein Tajmir (17931899) Marcello Stanzione (18474037) Eric F. Zaniewski (25300846) Sidney Mahan (20992044) Karl Hodel (25300849) Maci Meyers (25300852) Srihari Sampath (25300855) Christian Schmedt (25300858) Srinath C. Sampath (25300861) Tun Tun Lin (25300864) Feng Liu (21644351) Todd VanArsdale (21644381) Steven J. Isakoff (15037902) Amy Comander (25300867) Janice S. Kim (17931625) Seth A. Wander (18559724) Erik S. Knudsen (14948376) Agnieszka K. Witkiewicz (15121758) Lee Zou (16991183) Aaron N. Hata (15124479) Michael S. Lawrence (18474049) Wilhelm Haas (22180770) Andreas Varkaris (14845077) Ioannis Sanidas (17931631) Cancer Molecular and Cellular Biology Therapeutic Research and Development Clinical Research and Trials Methods and Technology Breast Cancer Cell Cycle CDKs and CDK inhibitors Clinical-stage Research Drug Mechanisms Cell cycle mechanisms of anticancer drug action Preclinical Models In vitro models of cancer Genomic alterations in models with acquired resistance to CDK4/6i 2026-10-02T00:00:00Z Dataset Dataset 10.1158/0008-5472.34055440 https://figshare.com/articles/dataset/Table_S1_from_CDK2_Inhibition_Exerts_RB-Independent_Antitumor_Activity_in_CDK4_6_Inhibitor_Resistant_HR_sup_sup_HER2_sup_sup_Breast_Cancer/34055440 CC BY